Smith & Nephew SNATS, Inc. (NYSE:SNN) Given Consensus Recommendation of “Hold” by Analysts

Smith & Nephew SNATS, Inc. (NYSE:SNN) has been assigned a consensus rating of “Hold” from the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $30.9250.

Several brokerages have recently weighed in on SNN. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Smith & Nephew SNATS in a research report on Thursday. Sanford C. Bernstein set a $31.85 price target on shares of Smith & Nephew SNATS in a research report on Monday, May 11th. The Goldman Sachs Group restated a “buy” rating on shares of Smith & Nephew SNATS in a research note on Monday, May 25th. Barclays downgraded Smith & Nephew SNATS from an “equal weight” rating to an “underweight” rating in a report on Wednesday. Finally, Canaccord Genuity Group dropped their target price on Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a report on Monday, May 11th.

Smith & Nephew SNATS Stock Performance

Shares of Smith & Nephew SNATS stock opened at $30.10 on Monday. Smith & Nephew SNATS has a 52-week low of $28.56 and a 52-week high of $38.79. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.14 and a quick ratio of 1.25. The company’s fifty day moving average price is $30.46 and its two-hundred day moving average price is $32.12.

Smith & Nephew SNATS Announces Dividend

The business also recently declared a dividend, which will be paid on Friday, November 6th. Investors of record on Friday, October 2nd will be paid a $0.312 dividend. The ex-dividend date of this dividend is Friday, October 2nd. This represents a yield of 205.0%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in SNN. BlackRock Inc. acquired a new stake in shares of Smith & Nephew SNATS in the 2nd quarter valued at $505,323,000. River Road Asset Management LLC increased its position in shares of Smith & Nephew SNATS by 13.8% during the 4th quarter. River Road Asset Management LLC now owns 3,169,644 shares of the medical equipment provider’s stock worth $103,996,000 after purchasing an additional 384,926 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Smith & Nephew SNATS by 5.2% during the 4th quarter. Goldman Sachs Group Inc. now owns 2,053,726 shares of the medical equipment provider’s stock worth $67,383,000 after purchasing an additional 100,697 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Smith & Nephew SNATS during the 2nd quarter valued at about $89,325,000. Finally, Dimensional Fund Advisors LP lifted its holdings in Smith & Nephew SNATS by 44.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,052,747 shares of the medical equipment provider’s stock valued at $33,436,000 after purchasing an additional 324,080 shares during the last quarter. 25.64% of the stock is owned by institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.